Alpha-7 beta-2 nicotinic acetylcholine receptor (α7β2 nAChR)

The alpha-7 beta-2 nicotinic acetylcholine receptor is a heteromeric ligand-gated ion channel composed of alpha-7 (CHRNA7) and beta-2 (CHRNB2) subunits [5, 7]. Primarily expressed in the mammalian brain, including the hippocampus and cerebral cortex, this receptor plays a critical role in modulating cognitive functions, synaptic plasticity, and neurotransmitter release [2, 5]. Unlike the more common homomeric alpha-7 receptor, the alpha-7 beta-2 heteromer exhibits distinct pharmacological properties, such as slower desensitization kinetics and unique sensitivity to amyloid-beta peptides [5, 7, 18]. It is also a key component of the cholinergic anti-inflammatory pathway, where it regulates immune responses through both ionotropic and metabotropic signaling [9, 12]. Due to its involvement in sensory gating and memory, it is a major therapeutic target for Alzheimer's disease, schizophrenia, and Parkinson's disease [3, 10, 15]. Pharmacological strategies include the use of selective agonists and positive allosteric modulators (PAMs) to enhance its activity, though challenges such as subtype selectivity and receptor desensitization remain significant hurdles in drug development [4, 8, 9]. The receptor's ability to integrate both electrical and biochemical signals makes it a versatile target for addressing complex neuropsychiatric and inflammatory conditions.

Other names

alpha7beta2 nAChRCHRNA7-CHRNB2 heteromerHeteromeric alpha7-containing nicotinic receptoralpha7beta2 nicotinic receptor

The α7β2 nAChR is a pentameric ligand-gated ion channel that facilitates the influx of cations, particularly Ca2+, upon activation by agonists such as acetylcholine [2, 4]. It also exhibits metabotropic properties, activating intracellular signaling pathways like JAK2/STAT3 and PI3K/Akt, which are crucial for its anti-inflammatory and neuroprotective effects [4, 9, 12]. Unlike homomeric α7 receptors, the α7β2 heteromer displays slower desensitization kinetics, allowing for more sustained signaling [5, 7].